Panoptes Pharma
Developing innovative small molecule drugs to treat eye diseases with high unmet medical need. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€4m (Public information from Dec 2020)
Company register number FN 399293x
Vienna Austria (HQ)
Authorizing premium user...